Verge Genomics, located in South San Francisco, California, is a pioneering biopharmaceutical company in the field of drug discovery. They have developed an advanced all-in-human AI-powered platform to expedite the process of discovering new drugs.
The platform leverages patient genetic information, gene expression data, and epigenomics to discover novel therapeutic gene targets, forecast the efficacy of medications, and categorize patient subgroups to enhance clinical trial success. The approach employed by Verge presents a groundbreaking prospect for uncovering drugs that significantly enhance patient results and fundamentally reduce the expenses associated with pharmaceutical development.